Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Omegamed:New infusion pump:future of healthcare -- Ignore unavailable to you. Want to Upgrade?

To: wallstreeter who wrote (6)	3/11/1998 2:42:00 PM
From: wallstreeter	Read Replies (1) \| Respond to of 12

This is a local magazine article . Aspire Magazine Have you ever spent time in the hospital? If so then you remember, like most people, how you couldn't wait to get home. Studies have also shown that the best place to recuperate from illness is in the home. In addition, many infections such as staph infections are bred in the hospital environment, so anything that could be done to make your hospital stay as short as possible would be considered a blessing. In the recent past, home health care has been one of the fastest growing segments in the health care industry. Earlier discharges from the hospitals reduces the risk of contracting hospital born germs, speeds up the recovery rate and also helps aid in reducing hospital costs. Skyrocketing insurance costs have put a strain on every as insurance carriers raise rates to compensate for higher hospital care costs. Omega Corporation is on company which is doing something to aid in shorter hospital stays. Omega has world wide patent rights on a new medical device called an Ambulatory Disposable Infusion Pump. Intravenous delivery of medicine is standard practice for a wide variety of therapeutic drugs. Infusion is the continuous flow of the drug into the blood stream usually at a slow rate, regulated by means of a drip system or by a metering pump.. Traditional devices include IV Drip,Bedside Pump & Ambulatory Pump. The Ambulatory Pump allows the patient to receive the appropriate medication while carrying on normal activities. In hospitals, patients are administered medication through the use of programmable electronic infusion Pumps. There are many disadvantages to these units. They are limited to short durations and uncontrollable flow rates. These machines are either battery or electrically powered and can be programmed to a complex delivery protocol. The cost of each unit is between $3000 to $5000. These pumps require a dispposable single use cassette and drug path system that cost $30.00 each. They are bulky and offer little convenience to the patient. However, they do a good job. Even so, what happens when the patient is ready to go home but still needs infusions of medicines of one type or the other. The OMEGA AMBULATORY DISPOSABLE INFUSION PUMP that Omega Corporation has patent rights on will soon be used. This is a multi million dollar market. The pump that Omega will be bringing to the market far surpasses anything now available. The Omega Pump is flow rate adjustable at any time during the duration of the infusion and the duration is expanded for hours up to ten days. The size and shape of the Omega Pump also makes it more convenient. All this, and it is cost effective not only in shorter hospital stays, but in the cost of the pump itself which is from 140-300% more cost effective than anything now available. The Home-care Nursing Industry are readily accepting this portable, disposable infusion Pump due to the low cost per unit and easy use. The delivery of medical services to patients within the patients home is the fastest growing segment of the entire health care market. Inventors and officers of Omega Corporation, Ulrich D. Cochran, Chairman of the Board and David C. Brown, President/Chief Executive officer, who both hold several medical device patents, have had discussions with smith-Kline Beecham, Hoffman La Roche, Bristol Myers and many others. All indicate an interest in the Omega infusion Pump. Insurance companies are also readily accepting this product due to patients now being able to go home sooner and use the Omega Disposable infusion Pump, thereby, lowering the cost of patient care. With the continued growth in home care,reliance on products to speed up hospital stays and insure proper home health benefits, it appears that the Omega Disposable Infusion Pump will be a leader in the field, outpacing the competition in cost, reliability and ease of use. With the rash of illness that has targeted this generation, any product that will lessen the cost of hospital stays and insure a quick and successful recovery is one to be reported. We look forward to the success of the Omega Disposable Infusion Pump and encourage continued support from the medical community as well as the private sector. by Robert L. Ridila